Concepedia

Augusto Villegas

AV

18

Publications

8.5K

Citations

14

H-Index

1993

Active since

Affiliations

Florida Cancer Specialists & Research Institute(Current)

Westmead Hospital

AstraZeneca (United Kingdom)

Moffitt Cancer Center

Istanbul University-Cerrahpaşa

Augusto Villegas is an author at Florida Cancer Specialists & Research Institute specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

1993–2024

18

Publications

18

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.4K citations · Full text

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC

Jhanelle E. Gray, Augusto Villegas, Davey B. Daniel et al. · Journal of Thoracic Oncology · 2019 · 423 citations · Full text

Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers

Solange Peters, Rolf A. Stahel, Lukas Bubendorf et al. · Clinical Cancer Research · 2018 · 224 citations · Full text

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

Luis Paz‐Ares, Alexander I. Spira, David Raben et al. · Annals of Oncology · 2020 · 217 citations · Full text

, , +6

Rows per page

1–5 of 18